NCT01254032View on ClinicalTrials.gov

Predictive Ability of the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test (CAT) for Acute Exacerbations (PACE) in Patients With COPD

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Pulmonary Disease, Chronic Obstructive
Trial Locations (19)

100

GSK Investigational Site, Taipei

404

GSK Investigational Site, Taichung

500

GSK Investigational Site, Changhua

807

GSK Investigational Site, Kaohsiung City

2137

GSK Investigational Site, Concord

4102

GSK Investigational Site, Woolloongabba

5042

GSK Investigational Site, Bedford Park

100730

GSK Investigational Site, Beijing

110001

GSK Investigational Site, Shenyang

200003

GSK Investigational Site, Shanghai

400038

GSK Investigational Site, Chongqing

430030

GSK Investigational Site, Wuhan

510080

GSK Investigational Site, Guangzhou

Unknown

GSK Investigational Site, Suzhou

100-032

GSK Investigational Site, Seoul

130-702

GSK Investigational Site, Seoul

134-090

GSK Investigational Site, Seoul

134-701

GSK Investigational Site, Seoul

138-736

GSK Investigational Site, Seoul

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY